Neurocrine Biosciences Inc. (NBIX)

$ 167.40
   
  • Change Today:
    $-2.00
  • 52 Week High: $182.21
  • 52 Week Low: $123.10
  • Currency: US Dollars
  • Shares Issued: 91.27m
  • Volume: 1,380,856
  • Market Cap: $15,278m
  • RiskGrade: 225
  • Beta: 0.01

NBIX Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

NBIX Fundamentals

Fundamentals data is not available for this company.

NBIX Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 3,973.45 1,001.66 734.96¢ 22.8 n/a n/a n/a 0.0%
31-Dec-27 4,566.64 1,359.22 1,009.43¢ 16.6 0.4 +37% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

NBIX ShareCast News

No recent information was found.

NBIX Top Newspaper Links

Also 24-Jun-2006 LA Times
Also 17-May-2006 LA Times
F.D.A. Demurs on Sleep Drug by Neurocrine 17-May-2006 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

NBIX Market Data

Currency US Dollars
Share Price $ 167.40
Change Today $ -2.00
% Change -1.18 %
52 Week High $182.21
52 Week Low $123.10
Volume 1,380,856
Shares Issued 91.27m
Market Cap $15,278m
Beta 0.01
RiskGrade 225

What The Brokers Say

Strong Buy 12
Buy 9
Neutral 4
Sell 0
Strong Sell 0
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Nov-2026

Time Volume / Share Price
15:59 142 @ $167.35
15:59 100 @ $167.35
15:59 100 @ $167.34
15:59 100 @ $167.39
15:59 100 @ $167.39

Top of Page